These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 11550996)

  • 1. PPARS in inflammation, atherosclerosis and thrombosis.
    Duez H; Fruchart JC; Staels B
    J Cardiovasc Risk; 2001 Aug; 8(4):187-94. PubMed ID: 11550996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation.
    Chinetti G; Fruchart JC; Staels B
    Inflamm Res; 2000 Oct; 49(10):497-505. PubMed ID: 11089900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis.
    Barbier O; Torra IP; Duguay Y; Blanquart C; Fruchart JC; Glineur C; Staels B
    Arterioscler Thromb Vasc Biol; 2002 May; 22(5):717-26. PubMed ID: 12006382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptors in inflammation control.
    Delerive P; Fruchart JC; Staels B
    J Endocrinol; 2001 Jun; 169(3):453-9. PubMed ID: 11375115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors with functions in the vascular wall.
    Chinetti G; Fruchart JC; Staels B
    Z Kardiol; 2001; 90 Suppl 3():125-32. PubMed ID: 11374025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors.
    Chinetti G; Gbaguidi FG; Griglio S; Mallat Z; Antonucci M; Poulain P; Chapman J; Fruchart JC; Tedgui A; Najib-Fruchart J; Staels B
    Circulation; 2000 May; 101(20):2411-7. PubMed ID: 10821819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of the peroxisome proliferator-activated receptors (PPARS) in the regulation of lipids and inflammation control].
    Bocher V; Chinetti G; Fruchart JC; Staels B
    J Soc Biol; 2002; 196(1):47-52. PubMed ID: 12134632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferator-activated receptors and the control of inflammation.
    Cabrero A; Laguna JC; Vázquez M
    Curr Drug Targets Inflamm Allergy; 2002 Sep; 1(3):243-8. PubMed ID: 14561188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages.
    Chinetti G; Griglio S; Antonucci M; Torra IP; Delerive P; Majd Z; Fruchart JC; Chapman J; Najib J; Staels B
    J Biol Chem; 1998 Oct; 273(40):25573-80. PubMed ID: 9748221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical interest of PPARs ligands.
    Vergès B
    Diabetes Metab; 2004 Feb; 30(1):7-12. PubMed ID: 15029092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of lipid and lipoprotein metabolism by PPAR activators.
    Gervois P; Torra IP; Fruchart JC; Staels B
    Clin Chem Lab Med; 2000 Jan; 38(1):3-11. PubMed ID: 10774955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of PPARs in atherosclerosis.
    Duval C; Chinetti G; Trottein F; Fruchart JC; Staels B
    Trends Mol Med; 2002 Sep; 8(9):422-30. PubMed ID: 12223313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decoding transcriptional programs regulated by PPARs and LXRs in the macrophage: effects on lipid homeostasis, inflammation, and atherosclerosis.
    Ricote M; Valledor AF; Glass CK
    Arterioscler Thromb Vasc Biol; 2004 Feb; 24(2):230-9. PubMed ID: 14592855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells.
    Marx N; Duez H; Fruchart JC; Staels B
    Circ Res; 2004 May; 94(9):1168-78. PubMed ID: 15142970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PPARs: transcription factors controlling lipid and lipoprotein metabolism.
    Bocher V; Pineda-Torra I; Fruchart JC; Staels B
    Ann N Y Acad Sci; 2002 Jun; 967():7-18. PubMed ID: 12079830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [PPARgamma and atheroma].
    Staels B
    Ann Endocrinol (Paris); 2002 Apr; 63(2 Pt 2):1S23-6. PubMed ID: 12037504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptors (PPARs) and their role in the vessel wall: possible mediators of cardiovascular risk?
    Marx N; Libby P; Plutzky J
    J Cardiovasc Risk; 2001 Aug; 8(4):203-10. PubMed ID: 11550998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators.
    Staels B; Koenig W; Habib A; Merval R; Lebret M; Torra IP; Delerive P; Fadel A; Chinetti G; Fruchart JC; Najib J; Maclouf J; Tedgui A
    Nature; 1998 Jun; 393(6687):790-3. PubMed ID: 9655393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of vascular inflammation by PPARs.
    Tham DM; Wang YX; Rutledge JC
    Drug News Perspect; 2003 Mar; 16(2):109-16. PubMed ID: 12792672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of peroxisome proliferator-activated receptor activators on the mRNA levels of genes involved in lipid metabolism in primary human monocyte-derived macrophages.
    Cabrero A; Cubero M; Llaverías G; Jové M; Planavila A; Alegret M; Sánchez R; Laguna JC; Carrera MV
    Metabolism; 2003 May; 52(5):652-7. PubMed ID: 12759900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.